✦ LIBER ✦

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

✍ Scribed by Busse, William W.; Katial, Rohit; Gossage, David; Sari, Suha; Wang, Bing; Kolbeck, Roland; Coyle, Anthony J.; Koike, Masamichi; Spitalny, George L.; Kiener, Peter A.; Geba, Gregory P.; Molfino, Nestor A.

Book ID: 119283796
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 530 KB
Volume: 125
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2010.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety profile and clinical activity of

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

✍ Joseph M Parker; Chad K Oh; Craig LaForce; S David Miller; David S Pearlman; Che 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 361 KB

609 A Phase 1 Study of MEDI-573, an Inve

609 A Phase 1 Study of MEDI-573, an Investigational Monoclonal Antibody That Targets IGF-I and IGF-II: Safety, Pharmacokinetics, and Antitumor Activity in Adults with Advanced Solid Tumors

✍ Haluska, P.; Menefee, M.E.; Plimack, E.R.; Rosenberg, J.E.; Northfelt, D.W.; LaV 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

415 A phase I study evaluating the safet

415 A phase I study evaluating the safety profile and pharmacokinetics of CS-1008 (Tigatuzumab), humanized monoclonal antibody targeting death receptor 5 (DR5), in Japanese patients with advanced solid tumours

✍ H. Nokihara; N. Yamamoto; Y. Yamada; H. Asahina; T. Shibata; Y. Seki; Y. Tamura; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] B33. ASTHMA THERAPY: NOVEL APPROACHES - A Phase 2b, Randomized Study To Evaluate The Clinical Activity And Safety Profile Of Subcutaneous MEDI-528, An Anti-IL-9 Monoclonal Antibody, In Adults With Uncontrolled Asthma

✍ Oh, Chad K.; McLaurin, Kimmie K.; Kim, Keunpyo; Hultquist, Micki; Molfino, Nesto 📂 Article 📅 2012 🏛 American Thoracic Society ⚖ 19 KB